Nicorette Frukt (Nicotine)

Nicotine, the active ingredient in Nicorette Frukt, is a nicotine replacement therapy presented as a fruit‑flavoured oromucosal lozenge for buccal use. It helps adult smokers manage nicotine withdrawal and supports smoking cessation. GNH USA supplies Nicorette Frukt as a licensed, GDP‑compliant international pharmaceutical supplier serving pharmacies and clinics worldwide.

Nicorette Frukt is a nicotine replacement product used within the smoking cessation pathway. - Smoking cessation: helps adult smokers reduce cravings and withdraw from nicotine. - Nicotine dependence: supports gradual reduction of nicotine intake in dependent individuals. - Relapse prevention: assists former smokers in maintaining abstinence from tobacco.

Common Side Effects: - Mouth irritation: mild soreness or tingling in the oral cavity. - Nausea: transient feeling of queasiness after use. - Increased salivation: excess saliva production during lozenge dissolution. - Throat irritation: discomfort or tickle in the throat. Serious or Rare Side Effects: - Allergic reaction: rash, itching, or swelling requiring medical attention. - Chest pain: unexpected discomfort that may indicate cardiac issues. - Severe skin rash: widespread erythema or blistering. - Anaphylaxis: rare life‑threatening hypersensitivity reaction.

Precautions should be taken when using Nicorette Frukt to ensure safe and effective use. - Assess nicotine dependence level: evaluate before initiating therapy. - Avoid use in children: not recommended for individuals under 18 years of age. - Monitor cardiovascular status: use with caution in patients with heart disease. - Do not use with other nicotine products: avoid simultaneous use to prevent overdose. - Store at ambient temperature: keep in the original pack, protect from moisture and heat.

Nicotine may interact with other medicines, requiring attention to avoid adverse outcomes. Major Interactions (Avoid): - Concurrent use of monoamine oxidase inhibitors: may increase hypertensive risk. - Use with other nicotine replacement products: risk of nicotine overdose. Moderate Interactions (Monitor Closely): - CYP2A6 inhibitors (e.g., methoxsalen): may alter nicotine metabolism. - Beta‑blockers: nicotine may affect heart rate, monitor cardiovascular response. - Antidepressants (SSRIs): possible increased side effects, monitor patient closely.